Literature DB >> 8536577

Lumbrical-interosseous latency comparison in the diagnosis of carpal tunnel syndrome.

G L Sheean1, M K Houser, N M Murray.   

Abstract

We examined 66 hands referred with suspected carpal tunnel syndrome (CTS) using the second lumbrical-interosseous distal motor latency difference (2LI-DML) as well as standard tests: Forty-nine cases of CTS were diagnosed by the standard tests, 48 of whom had an abnormal median-ulnar palmar velocity comparison and 48 an abnormal 2LI-DML. The results of these 2 tests were closely correlated. The 2LI-DML supported the diagnosis of CTS in all cases except one, where the result was borderline. In one suspected case the 2LI-DML was the only abnormality. In 9 severe cases no median palmar responses could be obtained but an abnormal 2LI-DML was found. We conclude that the 2LI-DML is as sensitive as the palmar comparison and thus will support the diagnosis of CTS made by standard tests by providing an additional abnormality but that its routine use is unlikely to increase the diagnostic yield. Its value therefore may be in mild cases where the median-ulnar palmar comparison is normal or equivocal and in severe cases where standard test responses are unobtainable. It has also proved useful as a quick and simple screening test for CTS on the asymptomatic side.

Entities:  

Mesh:

Year:  1995        PMID: 8536577     DOI: 10.1016/0924-980x(95)00197-s

Source DB:  PubMed          Journal:  Electroencephalogr Clin Neurophysiol        ISSN: 0013-4694


  2 in total

1.  Nerve conduction studies of median motor nerve and median sensory branches according to the severity of carpal tunnel syndrome.

Authors:  Hye Jin Lee; Hee Kyu Kwon; Dong Hwee Kim; Sung Bom Pyun
Journal:  Ann Rehabil Med       Date:  2013-04-30

2.  Diagnostic Value of the Second Lumbrical-Interosseous Distal Motor Latency Comparison Test in Severe Carpal Tunnel Syndrome.

Authors:  SangHun Lee; DongHyun Kim; Hee-Mun Cho; Ho-Sung Nam; Dong-Sik Park
Journal:  Ann Rehabil Med       Date:  2016-02-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.